Intelligent Bio Solutions Inc.
INBS
$2.36
$0.010.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 18.29% | -19.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.29% | -19.34% | |||
| Cost of Revenue | 20.23% | -26.37% | |||
| Gross Profit | 16.47% | -11.31% | |||
| SG&A Expenses | 5.20% | -12.14% | |||
| Depreciation & Amortization | 3.02% | -7.09% | |||
| Other Operating Expenses | -127.92% | 62.39% | |||
| Total Operating Expenses | 14.19% | -8.94% | |||
| Operating Income | -12.78% | 4.72% | |||
| Income Before Tax | -6.81% | 10.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.81% | 10.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -23.33% | -25.00% | |||
| Net Income | -6.91% | 10.24% | |||
| EBIT | -12.78% | 4.72% | |||
| EBITDA | -23.07% | 8.01% | |||
| EPS Basic | 36.25% | 19.31% | |||
| Normalized Basic EPS | 35.67% | 12.40% | |||
| EPS Diluted | 36.25% | 19.31% | |||
| Normalized Diluted EPS | 35.67% | 12.40% | |||
| Average Basic Shares Outstanding | 67.70% | 11.24% | |||
| Average Diluted Shares Outstanding | 67.70% | 11.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||